Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
16 studies found for:    7165009 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Conditions: Neoplasms, Unknown Primary;   CUP;   Metastatic Disease;   Poorly Differentiated Adenocarcinoma;   Poorly Differentiated Carcinoma;   Squamous Carcinoma Poorly Differentiated
Intervention:
2 Recruiting Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: vemurafenib and cobimetinib
3 Active, not recruiting Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology
Condition: Cancer
Intervention: Behavioral: MBSR
4 Recruiting An Investigation of TAS-119 Monotherapy and in Combination With Docetaxel
Condition: Advanced Solid Tumors
Intervention: Drug: TAS-119
5 Recruiting A Phase 1 Study of KBP-5209 in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: KBP-5209
6 Enrolling by invitation Exercise in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Other: Exercise
7 Unknown † A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT
Condition: Metastatic Seminoma
Intervention: Drug: Carboplatin AUC-10
8 Recruiting Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
Conditions: Adult Women;   Metastatic Breast Cancer;   Estrogen Receptor Positive
Intervention: Drug: Cholecalciferol
9 Withdrawn A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
10 Completed The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy.
Conditions: Acute Calculous Cholecystitis;   Acute Acalculous Cholecystitis
Intervention:
11 Active, not recruiting 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
Condition: Clear Cell Renal Cell Carcinoma
Intervention: Drug: Dovitinib
12 Terminated
Has Results 		Intraoperative MRI-guidance in Frameless Stereotactic Biopsies
Condition: Primary Brain Tumour
Interventions: Device: iMRI-guided brain tumour biopsy;   Device: Stereotactic frameless brain tumour biopsy
13 Completed Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212
Conditions: Solid Tumours;   Cancer
Intervention: Drug: GSK1120212
14 Withdrawn Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies
Conditions: Pain;   Cancer
Intervention: Procedure: EUS-guided Celiac Plexus Neurolysis
15 Completed
Has Results 		A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Condition: Head and Neck Neoplasms
Interventions: Drug: Pemetrexed;   Drug: Cetuximab;   Drug: Cisplatin;   Dietary Supplement: Folic Acid;   Dietary Supplement: Vitamin B12
16 Terminated Anidulafungin in Patients With Hematologic Malignancies
Condition: Hematologic Malignancies
Intervention: Drug: Anidulafungin
To Top

† Indicates status has not been verified in more than two years